Unione Europea - croato - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cjepiva - infanrix hexa je indiciran za primarne i booster cijepljenje dojenčadi protiv difterije, tetanusa, protiv pertusisa, hepatitisa b, poliomijelitisa i bolesti uzrokovane haemophilus influenzae tip b.

Croazia - croato - HALMED (Agencija za lijekove i medicinske proizvode)

remedica ltd., aharnon street, limassol industrial estate, limassol, cipar - sorafenibtosilat - filmom obložena tableta - 200 mg - urbroj: jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku sorafenibtosilata)

Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "farmax" doo danilovgrad - medicinska sredstva za zaštitu pacijenata i sredstva za inkontinenciju (isključujući ličnu zaštitnu opremu - ppe)

Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

društvo za spoljnu i unutrašnju trgovinu, zastupanje, posredovanje, inženjering i usluge "businessmontenegro" podgorica - neaktivna implantabilna medicinska sredstva

Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"netpharm" druŠtvo sa ograniČenom odgovornoŠĆu za zastupanje, spoljnu i unutraŠnju trgovinu podgorica - medicinska sredstva za jednokratnu upotrebu

Unione Europea - croato - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Unione Europea - croato - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastična sredstva - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Unione Europea - croato - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Croazia - croato - HALMED (Agencija za lijekove i medicinske proizvode)

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - sorafenibtosilat - filmom obložena tableta - 200 mg - urbroj: svaka filmom obložena tableta sadrži 200 mg sorafeniba (u obliku tosilata)

Croazia - croato - HALMED (Agencija za lijekove i medicinske proizvode)

mylan ireland limited, unit 35/36 grange parade, baldoyle industrial estate, dublin 13, irska - sorafenibtosilat - filmom obložena tableta - 200 mg - urbroj: jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku tosilata)